Miltenyi Biotec
Miltenyi Biotec makes the CliniMACS Prodigy, the closed cell-processing device many academic CAR-T programmes are built on.
Private German company supplying magnetic cell separation (CliniMACS), closed automated manufacturing (Prodigy), lentiviral vectors, and its own CAR-T candidates (zamtocabtagene autoleucel, MB-CART2019.1, a CD20/CD19 bispecific CAR-T in late-stage trials for lymphoma). A backbone of point-of-care cell manufacturing in Europe and Asia.
Pages like this
not linked directly; found by shared links- CompanyCellares
Shares Point-of-care and decentralised cell manufacturing, Closed automated cell-therapy manufacturing and the tag supporting.
- CompanyGalapagos
Shares Point-of-care and decentralised cell manufacturing and the tag supporting.
- CompanyCytiva (Danaher)
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- CompanyTerumo Blood and Cell Technologies
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- TechnologyCell-therapy release and potency testing
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- CompanyLonza
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- TermVein-to-vein time and manufacturing slots
Shares Point-of-care and decentralised cell manufacturing, Closed automated cell-therapy manufacturing.